Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Companion Diagnostics

Charles Mathews's Biography

Charles Mathews, Vice President, Boston Healthcare

Mr. Mathews has worked on a variety of reimbursement projects identifying public and private payer coverage channels, coding options, and pricing and payment possibilities for drugs, diagnostics, and medical devices. His specific area of expertise is in diagnostics, with a focus on value-based pricing for laboratory tests and molecular diagnostics, as well as with global companion diagnostic launch strategies. His experience further includes work with test and platform developers and laboratories, novel medical/surgical devices, drug/diagnostic combinations, and pharmaceutical product launches. Mr. Mathews’ prior experience includes working on health policy as a legislative aide on Capitol Hill. He has also worked for the government affairs office of Genentech and has participated in a National Institutes of Health sponsored clinical trial which focused on genetic testing for Alzheimer’s disease. Mr. Mathews has a master’s degree in public policy from Duke University and completed his undergraduate work at Colgate University.

Charles Mathews Image

Companion Diagnostics: Aligning Development, Commercialization, and Market Access

Tuesday, 28 October 2014 at 14:30

Add to Calendar ▼2014-10-28 14:30:002014-10-28 15:30:00Europe/LondonCompanion Diagnostics: Aligning Development, Commercialization, and Market

Ideally pharmaceutical innovators identify a companion diagnostic need early in the development process and identify an in vitro diagnostic partner that is able to not only support the execution of testing during the clinical trial but also launch the test globally when the drug is approved.  However, this is often not the case.  Variables in immediate testing needs, difficult commercialization pathways, and misaligned incentives lead to disconnects between the promise of CDx and the realities.  This presentation will provide an overview of companion diagnostic development and launch/distribution options and market access pathways.  It will review the needs and capabilities of various stakeholders (drug, IVD, lab, CRO, etc.) and not only point out where some of the disconnects lie but also provide suggestions for incorporating stage appropriate activities into drug development and CDx commercialization/market access planning and partnering/deal-terms.

Add to Calendar ▼2014-10-27 00:00:002014-10-28 00:00:00Europe/LondonCompanion